Pemetrexed in Combination With Erlotinib as a Salvage Treatment in Patients With Metastatic Biliary Tract Cancer (BTC) Who Failed Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study
Clinical trial NCT03110484 · UNKNOWN
Trial details
- NCT number
- NCT03110484
- Sponsor
- Samsung Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-09
- Primary completion
- 2023-06-14
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.